Anthem Biosciences Limited (BOM:544449)
666.70
-19.95 (-2.91%)
At close: Mar 4, 2026
-7.80% (1Y)
| Market Cap | 374.90B |
| Revenue (ttm) | 20.02B |
| Net Income (ttm) | 4.85B |
| Shares Out | n/a |
| EPS (ttm) | 8.58 |
| PE Ratio | 77.35 |
| Forward PE | 55.72 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,045 |
| Average Volume | 18,570 |
| Open | 660.05 |
| Previous Close | 686.65 |
| Day's Range | 658.00 - 676.15 |
| 52-Week Range | 579.45 - 873.25 |
| Beta | n/a |
| RSI | 48.34 |
| Earnings Date | Feb 5, 2026 |